Search results
Body
Showing 81-90 of 255 results
More than 10 studies presented at the European Society of Cardiology Congress revealed new findings on the far-reaching benefits of semaglutide.
Since the first SGLT2 inhibitor drug was approved in 2013, the medications have gone from targeting glucose-lowering to also providing cardiac protection and heart benefits.
PET, or positron emission tomography, uses higher energy isotopes to achieve a better image of the heart than the standard nuclear camera. Although PET scanners have been used for brain studies and oncology, they’ve fairly new to cardiology.
As the U.S. population ages, valvular heart disease has become more prevalent. Simultaneously, advanced and less-invasive treatments are becoming available.
While therapeutic hypothermia may help improve some outcomes in patients whose hearts stop suddenly outside the hospital, it doesn't appear to provide benefit when cardiac arrest happens in a hospital setting, according to a study published in the Journal of the American Medical Association.
Dr. John Spertus reported the health status analysis of the EXPLORER-HCM Trial at the ACC Scientific Session.
Few fields can lay claim to the level of advancements and breakthroughs as heart failure in the last decade.
The Wall Street Journal invited Dr. James O’Keefe, MD, director of preventive cardiology at Saint Luke’s Mid America Heart Institute, to explain the potential risk and share tips on how you can protect your heart during the big game.
James O’Keefe, MD, a co-investigator of this study, and director of preventive cardiology at Saint Luke’s Mid America Heart Institute, talked with KCTV about these new findings.
On average, survival benefits of CPR for cardiac arrest could be three times as high for white adults compared to Black adults and twice as high for men compared to women.